Frontlight ResearchEarly access
Trial site
Bangalore
- 7running trials
- 6closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Chronic spontaneous urticaria2 trials
- Coronary artery disease2 trials
- Familial hypercholesterolaemia2 trials
- IgA nephropathy2 trials
- Chronic kidney disease1 trial
- Diabetic eye disease1 trial
- Lung cancer1 trial
- Lupus (SLE)1 trial
- Sjögren's disease1 trial
- Stroke1 trial
- Vitiligo1 trial
- Phase
- Phase 39 trials
- Phase 22 trials
- Phase 42 trials
- Status
- Active, not recruiting6 trials
- Completed6 trials
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals13 trials
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Vitiligo1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026